On questions around the rising trend of anti-aging movements, Dr Bishen stressed that a healthy lifespan, focused on prevention through lifestyle changes like nutrition and exercise, holds more value than chasing unproven longevity trends like plasma or gene therapy
Bryan Johnson even floated the idea of auctioning off or donating his plasma following future treatments, calling it 'liquid gold.'
The guidance against the use of convalescent plasma, a component of blood that is rich in antibodies, was published in the British Medical Journal based on results from 16 trials involving more than 16,000 patients with varying degrees of coronavirus infection, WHO said.
The decision comes a day after members of ICMR's National Task Force said they were not in favour of continuing the plasma therapy on COVID-19 patients due to its ineffectiveness and inappropriate use in several cases.
One of India's top vaccine experts Dr Gagandeep Kang spoke to Moneycontrol's Chandra R Srikanth on the Government's vaccination roadmap, why there should be central procurement, if it is advisable to take the second dose of Covishield after 12 weeks and why plasma therapy should be dropped. She also spoke about when the second wave of Coronavirus began to taper in India.
In the plasma therapy, antibodies from the blood of a patient who has recovered from COVID-19 are used to treat serious patients.
Raising concerns that plasma therapy may even turn counter-productive and catalyse the development of more virulent strains, the letter addressed to Principal Scientific Advisor Dr Vijay Raghavan stated: “This raises the possibility of more virulent strains developing due to irrational use of plasma therapy which can fuel the pandemic.”
Delhi is among 10 states that account for 73.78 per cent of the new 3,68,147 COVID-19 cases registered in a day, according to the Health Ministry. It reported 20,394 new cases, 407 deaths in the past 24 hours.
The United States and India have authorised convalescent plasma for emergency use. Other countries, including Britain, are collecting donated plasma so that it could be widely rolled out if shown to be effective
A trial was earlier conducted by the ICMR across 39 hospitals in the country to find out if plasma therapy COVID-19 fatality or slows the progression of the disease.
US FDA has approved the use of blood plasma from recovered coronavirus patients as a treatment against the disease that has killed over 176,000 in the US
AIIMS Director Dr Randeep Guleria said on August 6 that no clear mortality benefit of convalescent plasma therapy was seen during a trial conducted among 30 COVID-19 patients
Since the outbreak of the pandemic, Uber has launched multiple initiatives to support the government and communities across the country.
Addressing an online media briefing, the chief minister said that there has been a spike in demand for plasma over the past 4-5 days, after the opening of a plasma bank in Delhi.
While making the statement, Singhvi recounted how Delhi Health Minister Satyendar Jain survived a severe COVID-19 infection because of plasma therapy.
The report, published in the journal Mayo Clinic Proceedings on Thursday, assessed the seven days following transfusion for hospitalised patients between April 3 and June 11 who were deemed at risk of progressing to a severe or life-threatening condition.
Thousands of coronavirus patients in hospitals around the world have been treated with so-called convalescent plasma — including more than 20,000 in the US — with little solid evidence so far that it makes a difference. One recent study from China was unclear while another from New York offered a hint of benefit.
Plasma therapy is being used on experimental basis to treat serious cases of COVID-19 in India and other countries. Taking advantage of the hype surrounding it, fraudsters are offering to sell plasma (a component of blood) of recovered patients, which is supposed to contain antibodies for the virus, as a "miracle cure" on Dark Net, said Yashasvi Yadav, Special Inspector General of Police, Maharashtra Cyber.
The purpose of the clinical trials is to understand the efficacy of blood plasma of a recovered COVID-19 patient in the treatment of others suffering from the disease, official said.
The science and technology ministry has reportedly earmarked 42 existing drugs, narrowed down from a list of at least 2,100 approved drugs, for repurposing.
SMS medical team members to submit data to ICMR once they complete plasma therapy on 20 patients.
Since he had high blood pressure and diabetes, he was under the continuous observation of doctors in the isolation ward, KGMU Vice Chancellor Bhatt said.
The announcement came days after the centre said that plasma therapy for treatment of coronavirus patients is at an experimental stage and it has the potential to cause life-threatening complications.
According to officials, patients who have recovered from COVID-19 have been appealed to come forward as donors, as anti-bodies of cured patients will be used to treat critically ill under this therapy.
Addressing an online media briefing, Kejriwal said more clinical trials of plasma therapy will take place over the next two-three days, and his government will seek the Centre's nod next week for using the technique on all seriously ill COVID-19 patients in the city.